Medpace
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Ohio, United States · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
5375 Medpace Way, Cincinnati, Ohio, 4522...Phone Number
(513) 579-9911Website
www.medpace.comRevenue
$2.7 BillionStock Symbol
MEDPIndustry
ZI Rank: 4
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
5
7
2
2
3
4
About Medpace
Medpace Holdings, Inc. is a global clinical research organization that provides comprehensive clinical development services to biotechnology companies, pharmaceutical manufacturers, and medical device organizations. Headquartered in Cincinnati, Ohio, the company specializes in supporting the development of medical therapies from early-stage research through late-stage clinical trials and regulatory approval processes. Through its scientifically focused operating model, Medpace has established itself as one of the leading independent contract research organizations serving the global life sciences industry.Explore more
Medpace Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Medpace your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Medpace launches new products
Click to see if Medpace had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Medpace, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Medpace has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Medpace
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Medpace has new funding data
Check out if Medpace is spiking on competitors!
Earning: See what the market has to say on Medpace recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Medpace as Masked Content
Find 2 more new buyers
Compare Similar Companies to Medpace
Compare insights from companies similar to Medpace, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$718.5M
1K - 5K
Private
-
1986
BL
Barry LedermanChief Financial Officer & Chief Financial Officer, Private Equity Private Equity
Company Profile Activity
Activity Insights
Medpace is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Medpace is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Medpace.
Medpace financials insights
Gather financial insights about Medpace, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Stock Offering
$161M
Medpace Tech Stack
A closer look at the technologies used by Medpace
See more technologies
Most Recent Scoops
Earnings
Medpace has reported net income of $121.4 million for Q2 2026, an increase of 34.5% compared to $90.3 million in Q2 2025, with net income per diluted share of $4.25 versus $3.10 in the prior year period. Year-to-date net income was $245.2 million, an increase of 19.7% compared to $204.9 million in the comparable prior year period, with year-to-date net income per diluted share of $8.53 versus $6.79 in the comparable prior year period.
Earnings, Finance
Earnings
Medpace has reported the repurchase of approximately 706,000 shares for $294.7 million during Q2 2026, with $527 million remaining under the company's share repurchase authorization program as of June 30, 2026.
Spending/Investment, Share Placement, Finance
Earnings
Medpace has reported net new business awards entering backlog of $795.7 million in Q2 2026, an increase of 28.2% from the prior year, resulting in a net book-to-bill ratio of 1.13. Ending backlog as of June 30, 2026 was approximately $3 billion, an increase of 4.9% from the prior year, with approximately $1.96 billion projected to convert to revenue in the next 12 months.
Earnings, Accounting, Financial Reporting, Finance
Earnings
Medpace has reported EBITDA of $153.4 million for Q2 2026, an increase of 17.6% compared to $130.5 million in Q2 2025, with an EBITDA margin of 21.7% versus 21.6% in the prior year period. Year-to-date EBITDA was $302.8 million, an increase of 21.5% from the comparable prior year period, with a year-to-date EBITDA margin of 21.4%, flat compared to the prior year period.
Earnings, Finance
Earnings
Earnings, Forecasting, Finance, Tax
Medpace News & Media
MEDP DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class Action - MEDP
NEW YORK, June 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the “Class Period”), of the important June 8, 2026 lead plaintiff deadline.Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
New class action for Medpace (MEDP) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 6/5/2026Medpace Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MEDP
LOS ANGELES, June 5, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated...MEDPACE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class Action - MEDP
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the “Class Period”), of the important June 8, 2026 lead plaintiff deadline.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Medpace
Sign Up For FreeTo access detailed company insights
Medpace Holdings, Inc. is a global clinical research organization that provides comprehensive clinical development services to biotechnology companies, pharmaceutical manufacturers, and medical device organizations. Headquartered in Cincinnati, Ohio, the company specializes in supporting the development of medical therapies from early-stage researc... Read More
